Evaluating Phase & Product Appropriate Bioconjugate Development

9:00 am - Wednesday 10th March 2027

Exploring the differing development approaches of ADCs across the preclinical to commercial spectrum
Understanding how the bioconjugate landscape now encompasses a wide variety of modalities with differing mechanisms of action and molecular structures
Exploring relevant examples of how the requirements for process and analytical development can vary between different conjugates